
Tilray Brands, Inc.’s (NASDAQ:TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support patients through their medical cannabis journey.
Blair MacNeil, president, Tilray Canada, stated, "We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community. Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."